PMCB
PharmaCyte Biotech·NASDAQ
--
--(--)
--
--(--)
PMCB fundamentals
PharmaCyte Biotech (PMCB) expects to report earnings on Sep 14, 2022, with estimated revenue of -- (YoY 0.00%), and EPS at -0.07 (YoY +89.06%).
Revenue estimate / YoY
--
0.00%
EPS estimate / YoY
-0.07
+89.06%
Report date
Sep 14, 2022
EPS
Revenue
Revenue & Expenses
Key Indicators
PharmaCyte Biotech (PMCB) key financial stats and ratios, covering profitability, financial health, and leverage.
PharmaCyte Biotech (PMCB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
PharmaCyte Biotech (PMCB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
PharmaCyte Biotech (PMCB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does PharmaCyte Biotech (PMCB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track PharmaCyte Biotech (PMCB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from PharmaCyte Biotech's earnings call?What factors drove the changes in PharmaCyte Biotech's revenue and profit?What guidance did PharmaCyte Biotech's management provide for the next earnings period?What does PharmaCyte Biotech do and what are its main business segments?What is the market's earnings forecast for PharmaCyte Biotech next quarter?What is the revenue and EPS growth rate for PharmaCyte Biotech year over year?What were the key takeaways from PharmaCyte Biotech’s earnings call?What is PharmaCyte Biotech's latest dividend and current dividend yield?
